Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coronary Stenosis
|
20 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Diabetes Mellitus
|
824 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Differentiated Thyroid Gland Carcinoma
|
80 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Azoospermia, Nonobstructive
|
22 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Impaired cognition
|
348 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1 | 2015 | 2015 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Breast Carcinoma
|
2793 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||
Coronary Artery Disease
|
1577 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.020 | 1.000 | 2 | 2011 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||
Colorectal Carcinoma
|
1962 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Coronary Arteriosclerosis
|
440 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Coronary heart disease
|
1178 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.060 | 1.000 | 6 | 2012 | 2019 | |||||
Malignant neoplasm of lung
|
1142 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.060 | 1.000 | 6 | 2012 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.060 | 1.000 | 6 | 2012 | 2019 | |||||
Lip and Oral Cavity Carcinoma
|
172 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.020 | 1.000 | 2 | 2010 | 2019 | |||||
Malignant neoplasm of mouth
|
184 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.020 | 1.000 | 2 | 2010 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.689 | 0.400 | 11 | 108223106 | 5 prime UTR variant | G/A | snv | 0.49 | 0.020 | 1.000 | 2 | 2019 | 2019 |